THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
191,057,703
Share change
+4,579,486
Total reported value
$930,418,803
Put/Call ratio
123%
Price per share
$4.87
Number of holders
139
Value change
+$25,180,934
Number of buys
79
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q1 2019

As of 31 Mar 2019, THERAPEUTICSMD INC - COM (TXMD) was held by 139 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 191,057,703 shares. The largest 10 holders included Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, DARUMA CAPITAL MANAGEMENT LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, and Rubric Capital Management LP. This page lists 139 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.